Stockreport

AbbVie: Increased Outlook For 2025 And Expansions Merit Continued "Strong Buy" Rating [Seeking Alpha]

AbbVie Inc.  (ABBV) 
Last abbvie inc. earnings: 5/1 07:43 am Check Earnings Report
US:NYSE Investor Relations: investors.abbvie.com/investor-overview
PDF ABBV's oncology segment is poised for expansion with trispecific antibody ISB 2001 for relapsed/refractory multiple myeloma and Epkinly's third FDA approval. Epkinly' [Read more]